Botha S, Fourie CMT, Schutte R, Eugen-Olsen J, Pretorius R, Schutte AE Soluble urokinase plasminogen activator receptor as a prognostic marker of all-cause and cardiovascular mortality in a black population. Int J Cardiol. 2015 Apr 1;184:631-636. doi: 10.1016/j.ijcard.2015.03.041. Epub 2015 Mar 4.
Dindo D, Demartines N, Clavien PA Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13.
Ghaferi AA, Dimick JB Importance of teamwork, communication and culture on failure-to-rescue in the elderly. Br J Surg. 2016 Jan;103(2):e47-51. doi: 10.1002/bjs.10031. Epub 2015 Nov 30. Review.
Hobson SA, Sutton CD, Garcea G, Thomas WM Prospective comparison of POSSUM and P-POSSUM with clinical assessment of mortality following emergency surgery. Acta Anaesthesiol Scand. 2007 Jan;51(1):94-100. Epub 2006 Nov 1.
Jeppesen MH, Tolstrup MB, Kehlet Watt S, Gögenur I Risk factors affecting morbidity and mortality following emergency laparotomy for small bowel obstruction: A retrospective cohort study. Int J Surg. 2016 Apr;28:63-8. doi: 10.1016/j.ijsu.2016.02.059. Epub 2016 Feb 18.
Jhanji S, Thomas B, Ely A, Watson D, Hinds CJ, Pearse RM Mortality and utilisation of critical care resources amongst high-risk surgical patients in a large NHS trust. Anaesthesia. 2008 Jul;63(7):695-700. doi: 10.1111/j.1365-2044.2008.05560.x. Epub 2008 May 16.
Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011 Aug;254(2):194-200. doi: 10.1097/SLA.0b013e318226113d.
Liu X, Shen Y, Li Z, Fei A, Wang H, Ge Q, Pan S Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study. BMC Anesthesiol. 2016 Jul 29;16(1):46. doi: 10.1186/s12871-016-0212-3.
Oliver CM, Walker E, Giannaris S, Grocott MP, Moonesinghe SR Risk assessment tools validated for patients undergoing emergency laparotomy: a systematic review. Br J Anaesth. 2015 Dec;115(6):849-60. doi: 10.1093/bja/aev350. Epub 2015 Nov 3. Review.
Sandquist M, Wong HR Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Rev Clin Immunol. 2014 Oct;10(10):1349-56. doi: 10.1586/1744666X.2014.949675. Epub 2014 Aug 21. Review.
Sankar A, Johnson SR, Beattie WS, Tait G, Wijeysundera DN Reliability of the American Society of Anesthesiologists physical status scale in clinical practice. Br J Anaesth. 2014 Sep;113(3):424-32. doi: 10.1093/bja/aeu100. Epub 2014 Apr 11.
Sheyin O, Davies O, Duan W, Perez X The prognostic significance of troponin elevation in patients with sepsis: a meta-analysis. Heart Lung. 2015 Jan-Feb;44(1):75-81. doi: 10.1016/j.hrtlng.2014.10.002. Epub 2014 Nov 18. Review.
Stoneham M, Murray D, Foss N Emergency surgery: the big three--abdominal aortic aneurysm, laparotomy and hip fracture. Anaesthesia. 2014 Jan;69 Suppl 1:70-80. doi: 10.1111/anae.12492. Review.
Tolstrup MB, Watt SK, Gögenur I Morbidity and mortality rates after emergency abdominal surgery: an analysis of 4346 patients scheduled for emergency laparotomy or laparoscopy. Langenbecks Arch Surg. 2017 Jun;402(4):615-623. doi: 10.1007/s00423-016-1493-1. Epub 2016 Aug 9.
Zeng M, Chang M, Zheng H, Li B, Chen Y, He W, Huang C Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis. Am J Emerg Med. 2016 Mar;34(3):375-80. doi: 10.1016/j.ajem.2015.11.004. Epub 2015 Nov 9.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.